BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 22521483)

  • 1. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
    Gómez-Hospital JA; Gomez-Lara J; Rondan J; Homs S; Lozano Martínez-Luengas I; Ferreiro JL; Roura G; Maristany J; Teruel L; Carro A; Avanzas P; Jara P; Esplugas E; Moris C; Cequier A
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):530-7. PubMed ID: 22521483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
    Park KW; Kang SH; Park KH; Choi DH; Lee HY; Kang HJ; Cho YS; Yeon TJ; Chung WY; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
    Int J Cardiol; 2011 Aug; 151(1):89-95. PubMed ID: 20605240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very long-term outcomes following drug-eluting stent implantation for unprotected left main coronary artery stenosis: a single center experience.
    Ielasi A; Latib A; Chieffo A; Takagi K; Mussardo M; Davidavicius G; Godino C; Carlino M; Montorfano M; Colombo A
    Rev Esp Cardiol (Engl Ed); 2013 Jan; 66(1):24-33. PubMed ID: 23041167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry).
    Palmerini T; Marzocchi A; Marrozzini C; Ortolani P; Saia F; Savini C; Bacchi-Reggiani L; Gianstefani S; Virzì S; Manara F; Kiros Weldeab M; Marinelli G; Di Bartolomeo R; Branzi A
    Am J Cardiol; 2006 Jul; 98(1):54-9. PubMed ID: 16784920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
    Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.
    Brennan JM; Dai D; Patel MR; Rao SV; Armstrong EJ; Messenger JC; Curtis JP; Shunk KA; Anstrom KJ; Eisenstein EL; Weintraub WS; Peterson ED; Douglas PS; Hillegass WB
    J Am Coll Cardiol; 2012 Feb; 59(7):648-54. PubMed ID: 22322080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
    Park DW; Seung KB; Kim YH; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Gwon HC; Jeong MH; Jang YS; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    J Am Coll Cardiol; 2010 Jul; 56(2):117-24. PubMed ID: 20451344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry.
    Chieffo A; Park SJ; Valgimigli M; Kim YH; Daemen J; Sheiban I; Truffa A; Montorfano M; Airoldi F; Sangiorgi G; Carlino M; Michev I; Lee CW; Hong MK; Park SW; Moretti C; Bonizzoni E; Rogacka R; Serruys PW; Colombo A
    Circulation; 2007 Jul; 116(2):158-62. PubMed ID: 17576862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergent versus elective percutaneous stent implantation in the unprotected left main: long-term outcomes from a single-center registry.
    Martin-Yuste V; Alvarez-Contreras L; Brugaletta S; Ferreira-Gonzalez I; Cola C; Garcia-Picart J; Martí V; Sabate M
    J Invasive Cardiol; 2011 Oct; 23(10):392-7. PubMed ID: 21972154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes after unprotected left main coronary artery stenting in an all-comers patient population.
    Ali M; Hanley A; McAdam B; O'Hanlon R; Gumbrielle T; Sheahan R; Foley DP
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E411-8. PubMed ID: 23404813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.
    Girasis C; Garg S; Räber L; Sarno G; Morel MA; Garcia-Garcia HM; Lüscher TF; Serruys PW; Windecker S
    Eur Heart J; 2011 Dec; 32(24):3115-27. PubMed ID: 21951630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.